Objective: To describe the process and impact of a service-level intervention on metabolic monitoring and follow-up of patients of a mental health service who were prescribed clozapine, and describe the metabolic health of these patients. Methods: The intervention – Let’s Get Physical – involved designating two months annually as ‘physical health months’, during which revised service protocol required metabolic monitoring for all eligible patients. Mixed methods were used to assess rates of monitoring at baseline, during the two physical health months, and follow-up and factors influencing practice. Data was analysed using a descriptive statistics and framework approach. Results: Monitoring was completed for around two thirds of eligi...
Background: Studies suggest that individuals with serious mental illness have higher rates of morb...
Mental health problems like schizophrenia, bipolar affective disorder and use of second generation a...
Introduction: Patients taking second-generation antipsychotics (SGAs) are at increased risk of devel...
To describe the process and impact of a service-level intervention on metabolic monitoring and follo...
Objective: To assess, among clozapine users, the rates of monitoring, presence and treatment of meta...
OBJECTIVE: International guidelines recommend monitoring for weight gain and metabolic disturbance i...
OBJECTIVES:: The primary objective of the study was to determine whether the Monitoring Outcomes of ...
OBJECTIVE: Clinicians are increasingly being asked to implement guideline recommendations into thei...
This project was designed to improve fidelity to ADA/APA metabolic monitoring guidelines for patient...
Aims and method: To describe and explain psychiatrists' responses to metabolic abnormalities iden...
OBJECTIVE: The authors sought to increase the rate of cardiometabolic monitoring for patients receiv...
Background: People with severe mental illness have poorer physical health, experience disparities in...
Severe mental disorders have a chronic course associated with a high risk for co-morbid somatic illn...
Background: People with severe mental illness have poorer physical health, experience disparities in...
BACKGROUND: People with severe mental illness have poorer physical health, experience disparities in...
Background: Studies suggest that individuals with serious mental illness have higher rates of morb...
Mental health problems like schizophrenia, bipolar affective disorder and use of second generation a...
Introduction: Patients taking second-generation antipsychotics (SGAs) are at increased risk of devel...
To describe the process and impact of a service-level intervention on metabolic monitoring and follo...
Objective: To assess, among clozapine users, the rates of monitoring, presence and treatment of meta...
OBJECTIVE: International guidelines recommend monitoring for weight gain and metabolic disturbance i...
OBJECTIVES:: The primary objective of the study was to determine whether the Monitoring Outcomes of ...
OBJECTIVE: Clinicians are increasingly being asked to implement guideline recommendations into thei...
This project was designed to improve fidelity to ADA/APA metabolic monitoring guidelines for patient...
Aims and method: To describe and explain psychiatrists' responses to metabolic abnormalities iden...
OBJECTIVE: The authors sought to increase the rate of cardiometabolic monitoring for patients receiv...
Background: People with severe mental illness have poorer physical health, experience disparities in...
Severe mental disorders have a chronic course associated with a high risk for co-morbid somatic illn...
Background: People with severe mental illness have poorer physical health, experience disparities in...
BACKGROUND: People with severe mental illness have poorer physical health, experience disparities in...
Background: Studies suggest that individuals with serious mental illness have higher rates of morb...
Mental health problems like schizophrenia, bipolar affective disorder and use of second generation a...
Introduction: Patients taking second-generation antipsychotics (SGAs) are at increased risk of devel...